United States · Series A startup

Who invested in Garuda Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $50MMar 2025
Investors
3
See who backed them

The rounds

  1. Mar 2025

Everyone who backed them

OrbiMedPrivate equity1round
Cormorant Asset ManagementPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Garuda Therapeutics

Who invested in Garuda Therapeutics?

Garuda Therapeutics's investors include OrbiMed, Cormorant Asset Management and Alexandria Venture Investments.

How much has Garuda Therapeutics raised?

Garuda Therapeutics has raised $50M across 1 round since 2025.

When did Garuda Therapeutics last raise?

Garuda Therapeutics's most recent round was a Series A of $50M in Mar 2025.

What was Garuda Therapeutics's biggest round?

Its most recent round, $50M in Mar 2025, is also its largest on record.

Who backed Garuda Therapeutics first?

Garuda Therapeutics's first round on record, in Mar 2025, was backed by OrbiMed, Cormorant Asset Management and Alexandria Venture Investments.

What stage is Garuda Therapeutics at?

Garuda Therapeutics's latest named round is a Series A, in Mar 2025.

Where is Garuda Therapeutics based?

Garuda Therapeutics is based in the United States.

Companies like Garuda Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.